CompletedNot Applicable

Luteal Phase-start Ovarian Stimulation With Corifollitropin Alfa

Spain44 participantsStarted 2018-05-08

Plain-language summary

To evaluate the effect of random-start of ovarian stimulation initiated in the early follicular or luteal phase on the pharmacokinetics and follicular dynamics and embryo euploidy rates in oocyte donors treated with identical ovarian stimulation protocols with corifollitropin alfa and GnRH antagonist pituitary downregulation

Who can participate

Age range18 Years – 35 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Healthy eligible oocyte donors
✓. Age 18-34 years
✓. AFC \>12 and AMH\>1.5 ng/ml
✓. BMI 19-28kg/m2
✓. Body weight \>60kg
✓. Both ovaries present
✓. Willing to participate in the study
✓. Willing to use non-hormonal contraception or not needing contraception Recipients will be eligible only if their partners' sperm which will be used for ICSI will be normal. Couples will be excluded in case of moderate to severe oligoasthenospermia.

Exclusion criteria

✕. Endometriosis
✕. AFC\>20
✕. PCOS
✕. Low ovarian reserve
✕. Endocrine abnormalities
✕. Hormonal contraception
✕. Contraindication of hormonal treatment
✕. History of Ovarian Hyperstimulation Syndrome or hyper-response (\> 30 follicles .

What they're measuring

Mean number of euploid embryos

Timeframe: 15-45 days following oocyte retrieval procedure

Trial details

NCT IDNCT03555942

SponsorFundacion Dexeus

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-11-30

View on ClinicalTrials.gov More Infertility trials